stockrow
Friday 6 November 2026
Export TFX’s income statement to Excel — free account
Teleflex Incorporated
TFX Healthcare Medical Instruments & Supplies
Teleflex Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $2.0 billion, up 17.2% from fiscal 2024.
- Revenue
- +0.15%
- EPS
- +342.0%
- Free cash flow
- +220.1%
- Total debt
- −39.4%
Quarter to September 2026, against a year earlier
151.46
0.69
−0.45%
Follow TFX
Alert me
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
28.99 | 75.36 | 58.88 | 37.68 | 57.00 | 31.68 | 32.24 | 33.04 | 122.74 | 0.00 |
Piotroski F-Score |
6 | 4 | 5 | 7 | 4 | 7 | 5 | 3 | 6 | 5 |
P/S ratio |
3.68 | 5.34 | 4.82 | 6.70 | 7.54 | 5.47 | 4.20 | 3.96 | 4.90 | 2.73 |
Altman Z-Score |
4.16 | 2.98 | 3.12 | 4.53 | 4.31 | 4.47 | 3.97 | 3.50 | 3.01 | 2.04 |
Altman Z″-Score (non-manufacturers) |
4.94 | 2.98 | 3.00 | 3.62 | 3.54 | 4.17 | 4.52 | 4.21 | 4.34 | 3.56 |
P/FCF ratio |
19.25 | 32.26 | 33.33 | 49.87 | 55.23 | 26.47 | 44.45 | 73.67 | 39.42 | 3,766.02 |
Beneish M-Score |
(2.68) | (2.49) | (2.60) | (2.32) | (2.57) | (2.61) | (2.37) | (2.17) | (3.15) | (2.21) |
P/Operating CF |
63.15 | 107.55 | 89.37 | 117.59 | 97.79 | 76.18 | 119.09 | (70.78) | 36.07 | (147.10) |
Dividend Safety Score |
— | — | — | — | — | — | — | — | — | 20 |
P/B ratio |
3.22 | 4.72 | 4.65 | 5.84 | 5.73 | 4.09 | 2.91 | 2.65 | 1.95 | 1.74 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 8.89 | 0.00 |
EV/Sales |
3.95 | 6.23 | 5.56 | 7.32 | 8.37 | 5.97 | 4.71 | 4.49 | 5.73 | 3.87 |
EV/EBITDA |
16.47 | 25.12 | 25.37 | 29.71 | 32.43 | 21.53 | 17.89 | 32.92 | 36.28 | 25.63 |
EV/Operating CF |
17.96 | 31.39 | 31.28 | 43.47 | 48.58 | 25.71 | 38.32 | 64.80 | 32.28 | 79.73 |
EV/FCF |
20.63 | 37.65 | 38.42 | 54.48 | 61.30 | 28.89 | 49.83 | 83.64 | 46.08 | 5,330.95 |
Quick Ratio |
1.91 | 1.40 | 1.24 | 1.28 | 1.43 | 1.22 | 1.21 | 1.10 | 0.73 | 0.95 |
Current Ratio |
2.77 | 2.33 | 2.12 | 2.32 | 2.63 | 2.10 | 2.43 | 2.32 | 2.27 | 2.54 |
Net Debt/EBITDA |
1.10 | 3.60 | 3.36 | 2.51 | 3.21 | 1.80 | 1.93 | 3.92 | 5.24 | 7.52 |
Debt/Assets |
26.60% | 36.39% | 34.39% | 30.25% | 34.65% | 26.92% | 24.70% | 24.10% | 23.33% | 38.02% |
Debt/Equity |
0.48 | 0.93 | 0.85 | 0.64 | 0.74 | 0.49 | 0.43 | 0.41 | 0.39 | 0.85 |
Asset Turnover |
0.48 | 0.43 | 0.39 | 0.41 | 0.38 | 0.40 | 0.40 | 0.24 | 0.23 | 0.28 |
Operating CF/Net income |
1.73 | 2.79 | 2.17 | 0.95 | 1.30 | 1.34 | 0.94 | 0.58 | 4.33 | (0.11) |
Capex/Depreciation |
(0.41) | (0.44) | (0.38) | (0.40) | (0.39) | (0.30) | (0.34) | (0.31) | (0.55) | (0.52) |
Interest Coverage |
5.81 | 4.51 | 3.12 | 5.25 | 6.36 | 9.43 | 9.21 | 2.99 | 1.24 | 1.18 |
| 11.44% | 6.68% | 8.08% | 16.72% | 10.62% | 13.69% | 9.34% | 8.42% | 1.60% | (24.47%) | |
| 6.12% | 3.03% | 3.22% | 7.33% | 4.98% | 6.92% | 5.26% | 4.93% | 0.95% | (12.90%) | |
ROIC |
7.59% | 5.35% | 4.63% | 5.74% | 4.86% | 6.50% | 5.74% | 2.63% | 1.14% | 1.37% |
Return on Tangible Assets |
22.42% | 14.84% | 18.48% | 39.31% | 24.72% | 40.69% | 28.44% | 27.83% | 6.16% | (54.08%) |
Average Days of Receivables |
53.15 | 58.82 | 54.61 | 58.88 | 56.84 | 49.83 | 53.47 | 94.52 | 48.69 | 63.30 |
Research and Development Expense of Revenue |
3.14% | 3.95% | 4.34% | 4.39% | 4.72% | 4.66% | 5.51% | 6.64% | 6.41% | 7.27% |
Selling, General and Administrative Expense of Revenue |
30.16% | 32.61% | 32.55% | 32.82% | 29.31% | 30.61% | 30.95% | 36.37% | 39.69% | 36.14% |
Intangible Assets out of Total Assets |
0.61 | 0.75 | 0.73 | 0.70 | 0.71 | 0.70 | 0.70 | 0.72 | 0.47 | 0.55 |
Share Based Compensation of Revenue |
0.90% | 0.90% | 0.92% | 1.04% | 0.82% | 0.82% | 0.98% | 1.59% | 1.53% | 1.29% |
Graham Net Nets |
(0.08) | (0.23) | (0.21) | (0.12) | (0.13) | (0.11) | (0.13) | (0.14) | (0.16) | (0.35) |
Graham Number |
78.00 | 64.09 | 74.10 | 120.40 | 107.98 | 136.86 | 122.29 | 126.97 | 54.59 | 0.00 |
Earnings Yield |
3.45% | 1.33% | 1.70% | 2.65% | 1.75% | 3.16% | 3.10% | 3.03% | 0.81% | (16.83%) |
Free Cash Flow Yield |
5.19% | 3.10% | 3.00% | 2.01% | 1.81% | 3.78% | 2.25% | 1.36% | 2.54% | 0.03% |
Revenue per Share |
43.12 | 47.69 | 53.59 | 56.18 | 54.58 | 60.07 | 59.51 | 36.45 | 36.29 | 44.66 |
Operating CF per Share |
9.48 | 9.47 | 9.52 | 9.46 | 9.40 | 13.94 | 7.31 | 4.39 | 6.45 | 2.17 |
Capex per Share |
(1.23) | (1.58) | (1.77) | (1.91) | (1.95) | (1.53) | (1.69) | (0.99) | (1.93) | (2.13) |
Free Cash Flow per Share |
8.25 | 7.90 | 7.75 | 7.55 | 7.45 | 12.41 | 5.62 | 3.40 | 4.51 | 0.03 |
Cash per Share |
12.55 | 7.41 | 7.82 | 6.52 | 8.09 | 9.52 | 6.23 | 4.74 | 5.29 | 8.48 |
Shareholders Equity per Share |
49.34 | 54.01 | 55.59 | 64.49 | 71.77 | 80.27 | 85.76 | 94.53 | 91.34 | 70.03 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
49.34 | 54.01 | 55.59 | 64.49 | 71.77 | 80.27 | 85.76 | 94.53 | 91.34 | 70.03 |
Free Cash Flow |
357.46 | 355.40 | 354.29 | 348.72 | 346.45 | 580.52 | 263.62 | 159.72 | 211.45 | 1.45 |
Working Capital |
755.75 | 644.93 | 653.71 | 743.28 | 882.40 | 749.00 | 829.49 | 800.66 | 821.76 | 1,176.31 |
Capital Expenditures |
(53.13) | (70.90) | (80.79) | (88.35) | (90.69) | (71.62) | (79.19) | (46.42) | (90.44) | (95.24) |
Net Current Asset Value |
(570.30) | (2,622.15) | (2,501.84) | (2,024.17) | (2,393.68) | (1,687.86) | (1,495.11) | (1,684.15) | (1,348.65) | (1,884.13) |
EV/EBIT |
23.08 | 35.94 | 42.31 | 45.11 | 50.19 | 31.23 | 26.29 | 52.53 | 94.01 | 65.12 |
Capex to Sales |
0.03 | 0.03 | 0.03 | 0.03 | 0.04 | 0.03 | 0.03 | 0.03 | 0.05 | 0.05 |
Price to Operating Income |
21.55 | 30.79 | 36.71 | 41.29 | 45.22 | 28.61 | 23.45 | 46.27 | 80.42 | 46.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.42 | 0.42 | 0.50 | 0.51 | 0.49 | 0.55 | 0.52 | 0.32 | 0.53 | 0.37 |
Cash ROIC |
9.62% | 7.09% | 7.01% | 6.72% | 5.60% | 9.60% | 4.37% | 2.47% | 3.42% | 0.02% |
Accounts Receivable Turnover |
6.99 | 6.95 | 6.88 | 6.61 | 6.24 | 7.22 | 7.04 | 4.02 | 5.07 | 6.96 |
Accounts Payable Turnover |
12.85 | 12.07 | 11.53 | 11.32 | 11.80 | 11.42 | 10.28 | 5.19 | 5.76 | 7.65 |
Inventory Turnover |
2.70 | 2.74 | 2.78 | 2.62 | 2.45 | 2.54 | 2.39 | 1.12 | 1.42 | 2.45 |
Average Days of Payables |
29.06 | 34.47 | 34.00 | 31.66 | 30.87 | 34.25 | 36.74 | 71.80 | 53.94 | 54.50 |
Days of Inventory on Hand |
132.37 | 148.23 | 136.30 | 146.62 | 154.52 | 138.37 | 167.59 | 339.97 | 169.10 | 169.28 |
Average Receivables |
267.20 | 308.93 | 356.08 | 392.48 | 406.87 | 389.32 | 396.20 | 426.15 | 335.10 | 286.16 |
Average Payables |
67.85 | 80.71 | 99.37 | 104.81 | 102.72 | 110.38 | 122.52 | 129.53 | 115.05 | 114.03 |
Average Inventory |
323.22 | 355.96 | 411.76 | 452.17 | 494.88 | 495.42 | 528.08 | 602.36 | 466.49 | 355.58 |
Average Assets |
3,881.49 | 5,036.35 | 6,229.74 | 6,293.91 | 6,731.19 | 7,012.14 | 6,899.89 | 7,230.30 | 7,315.23 | 7,022.58 |
Average Common Equity |
2,074.31 | 2,284.02 | 2,485.25 | 2,759.65 | 3,157.89 | 3,545.60 | 3,888.36 | 4,231.48 | 4,359.56 | 3,701.45 |
Columns are period end dates · fundamentals updated 6 Nov 2026